The safety, tolerability and preliminary efficacy of pd-l1 monoclonal antibody combined with lenalidomide in third-line post-treatment of patients with microsatellite stable advanced colorectal cancer: a phase I clinical stud
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: single arm:Pd-l1 monoclonal antibody and lenalidomide Primary outcome(s): Security;Tolerance Study Design: Single arm
创建时间：
2020-03-15
